Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
ACE Report #9026
Ace Report Cover General Orthopaedics

Hydroxyapatite + collagen vs. beta-tricalcium phosphate in bone substitution implantation

Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Efficacy and safety of porous hydroxyapatite/type 1 collagen composite implantation for bone regeneration: A randomized controlled study

J Orthop Sci. 2016 May;21(3):373-80.

Contributing Authors: S Sotome K Ae A Okawa M Ishizuki H Morioka S Matsumoto T Nakamura S Abe Y Beppu K Shinomiya

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


130 patients undergoing bone substitution implantation were randomized to one of two synthetic porous composite groups for the purpose of comparing the efficacy and safety throughout a 24-week period: (1) porous hydroxyapatite/collagen composite (HAp/CoL) or (2) porous beta-tricalcium phosphate (beta-TCP). Results demonstrated that a significantly larger proportion of patients in the HAp/CoL had "...

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.


Please Login or Join to leave comments.